Sign Up
Stories
Cencora Repurchases Walgreens Shares
Share
Biopharma Companies Announce Public Offe...
Celyad Oncology Expands Share Capital
Celyad Oncology Receives Notification
Reviva Pharmaceuticals to Present Therap...
Overview
API
Cencora, a leading global pharmaceutical solutions organization, has repurchased approximately $50 million in shares from Walgreens Boots Alliance under its share repurchase program. The repurchased shares will be held in treasury.
Ask a question
How does Cencora's share repurchase align with its overall financial and strategic goals?
How might Cencora's share repurchase impact its stock price and investor confidence?
What are the potential implications of Cencora's high ranking on the Fortune 500 for its business operations and market positioning?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage